Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Exercise with laser-pointer visual feedback for balance in Parkinson's

Official title: Effects of Visual Indicator Exercises for the Trunk and Lower Extremities on Activity and Participation in Parkinson's Disease

Run by Hasan Kalyoncu University · NCT07322939 · Data updated 2026-11-12

We will try adding laser-pointer visual feedback exercises to standard physiotherapy for people with mild-to-moderate Parkinson's to see if balance and mobility improve.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment32 (estimated)
SponsorHasan Kalyoncu University
Academic / other
Locations1 site (Gaziantep, Şahinbey)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedApril 5, 2026
Study endsMay 5, 2026
Registry record updatedJanuary 27, 2026
Trial IDNCT07322939 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people with idiopathic Parkinson's on oral medications only, classified as Hoehn and Yahr stage 1–3, who can attend supervised sessions and have sufficient vision to perceive visual feedback.

Probably not a fit

Those with advanced disease (beyond stage 3), significant visual impairment, other neurological or psychiatric disorders, or unstable musculoskeletal, cardiovascular, or vestibular conditions are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled study will enroll people with idiopathic Parkinson's (Hoehn and Yahr stages 1–3) at Hasan Kalyoncu University. Participants will be randomly assigned by sealed envelope to either a control group or an intervention group; both groups receive an 8-week, supervised standard exercise program (posture, strengthening, and balance) three days per week. The intervention group will also perform targeted trunk and lower-extremity exercises using a laser-pointer visual-feedback technique under physiotherapist supervision for the same 8-week schedule. Outcomes will focus on body structure/function, activity, and participation related to balance and postural control.

Why it matters

Potential benefit: If successful, adding visual-feedback exercises could improve balance, posture, and daily activity participation and may reduce fall risk for people with Parkinson's.

How similar studies have gone: Prior studies of visual cueing and visual-feedback techniques in Parkinson's have shown promising but mixed improvements in gait and balance, so this trial adds further, targeted evidence using a laser-pointer method.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Individuals diagnosed with idiopathic Parkinson's disease
* Disease severity classified as stage 1 to 3 according to the Modified Hoehn and Yahr Scale
* Patients receiving oral antiparkinsonian treatment only

Exclusion Critera

* Presence of musculoskeletal, cardiovascular, or vestibular disorders that may interfere with the completion of the assessments or treatment protocol
* Presence of additional neurological or psychiatric disorders other than Parkinson's disease
* Presence of visual impairment insufficient to perceive visual feedback

Where it's running

  • Hasan Kalyoncu University
    Gaziantep, Şahinbey, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.